Pafuramidine maleate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePafuramidine maleate
Drug Alias Namepafuramidina马来酸帕呋拉定pafuramidinumpafuramidineDB-289 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsHIV InfectionsTrypanosomiasis, AfricanTrypanosomiasis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAngolaUnited StatesSouth Africa +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesUncGeorgia State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmtech Pharmaceuticals IncBeijing Huayuanlong Medicine Technology Development Co Ltd
Active IndicationsN/A
Inactive IndicationsHIV InfectionsTrypanosomiasis, AfricanTrypanosomiasis +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG